Medical Weight Loss

semaglutide for weight loss

Semaglutide for Weight Loss: Comprehensive Examination and Details

The FDA authorized semaglutide (Wegovy), an injection given once a week, in June 2021 for the long-term treatment of obesity in adults when combined with regular exercise and a nutritious diet. Prior to FDA approval, during semaglutide clinical trials, patients had dropped 15% of their initial body weight. Kids 12 years old and older have

Semaglutide for Weight Loss: Comprehensive Examination and Details Read More »